메뉴 건너뛰기
The Lancet
Volumn 385, Issue 9963, 2015, Pages 114-
Pathological complete response in breast cancer
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;
EID: 84920624454     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60017-4     Document Type: Letter
Times cited : (8)
References (6)
  • 1
    • 84904188903 scopus 로고    scopus 로고
    • Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis
    • P Cortazar, L Zhang, M Untch et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 384 2014 164 172
    • (2014) Lancet , vol.384 , pp. 164-172
    • Cortazar, P.1    Zhang, L.2    Untch, M.3
  • 2
    • 84904212859 scopus 로고    scopus 로고
    • Defining success in neoadjuvant breast cancer trials
    • LA Carey, EP Winer Defining success in neoadjuvant breast cancer trials Lancet 384 2014 115 116
    • (2014) Lancet , vol.384 , pp. 115-116
    • Carey, L.A.1    Winer, E.P.2
  • 3
    • 84871842303 scopus 로고    scopus 로고
    • Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer
    • D Groheux, E Hindié, M Delord et al. Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer J Natl Cancer Inst 104 2012 1879 1887
    • (2012) J Natl Cancer Inst , vol.104 , pp. 1879-1887
    • Groheux, D.1    Hindié, E.2    Delord, M.3
  • 4
    • 84894285167 scopus 로고    scopus 로고
    • (18)F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations
    • A Cochet, I Dygai-Cochet, JM Riedinger et al. (18)F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations Eur J Nucl Med Mol Imaging 41 2014 428 437
    • (2014) Eur J Nucl Med Mol Imaging , vol.41 , pp. 428-437
    • Cochet, A.1    Dygai-Cochet, I.2    Riedinger, J.M.3
  • 5
    • 84856806192 scopus 로고    scopus 로고
    • Triple-negative breast cancer: Early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse
    • D Groheux, E Hindié, S Giacchetti et al. Triple-negative breast cancer: early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathologic complete response and are at a high risk of early relapse J Nucl Med 53 2012 249 254
    • (2012) J Nucl Med , vol.53 , pp. 249-254
    • Groheux, D.1    Hindié, E.2    Giacchetti, S.3
  • 6
    • 84883739924 scopus 로고    scopus 로고
    • HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment
    • D Groheux, S Giacchetti, M Hatt et al. HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment Br J Cancer 109 2013 1157 1164
    • (2013) Br J Cancer , vol.109 , pp. 1157-1164
    • Groheux, D.1    Giacchetti, S.2    Hatt, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.